DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Introducing: Coupon Analysis Threat Assessor

Pharma spent more than $20 Billion on manufacturer coupon programs in 2018 alone.

Despite this, many top brands are seeing declines or stagnation in market share.

  • How do you track your ROI?
  • How do you track your competitor’s coupon usage?
  • How do you track brand exposure to high deductible health plans?
  • How do you assess when you and your competitor’s brand is vulnerable to copay accumulators?


Coupon Market Share & Spending


  • Market share trends by brand as well as coupon utilization statistics; filterable by region.
  • Brand-by-brand comparison of manufacturer coupon spending and ROI.
  • Compare average income from brand fills that use coupons.

Copay Accumulator Analysis


  • Insight into brand vulnerability to the negative impacts of copay accumulators.
  • Timeline to identify when a patient is most likely to abandon therapy when exposed to a copay accumulator.
  • Identify how many patients could exhaust their coupon benefits when they are exposed to a copay accumulator.

High Deductible Health Plan Analysis


  • Through the combination of real world claims data, lives information and market research, DRG’s solution provides an interactive dashboard and insights model enabling our clients to…
  • Identify brand exposure to high-deductible health plans, and how often patients with an HDHP use coupons.
  • View how many brand fills likely occurred under a high-deductible plan and, of those, how many used coupons.
  • Determine how often patients under HDHPs filled their prescriptions using coupons.

Gain a Comprehensive View on Coupon Programs



  • Gain a deep understanding of the market landscape
  • Identify the key players within the market deploying coupon programs
  • Brand exposure to high deductible health plans


  • Assess the financial impacts by individual therapy class and drug level
  • Identify class and brand-level trends
  • Copay accumulator vulnerability by brand

Strategize, implement & measure

  • Develop comprehensive data-driven strategies
  • Deploy strategic initiatives to minimize financial & market share impacts
  • Target opportunities for market share growth

Product breakdown


DRG offers a truly unique combination of data and insights with at-a-glance views of:

  • COPAY ASSISTANCE UTILIZATION TRACKER – Detail at the national and state levels; By therapy area and PBM.
  • HIGH DEDUCTIBLE HEALTH PLAN ANALYSIS – Identify brand exposure to HDHP.
  • THREAT ASSESSMENT – Real world data supported insights on impacts by therapy class, drug and geographical region.
  • DRUG ANALYSIS – Assess drug-level risk, financial impacts, coupon ROI, and compare your drug with competing therapies.
  • PBM ENROLLMENT OVERVIEW – Includes number of potentially impacted patients.
  • LEGISLATION – Key state level policies and regulations.